MPR Associates Discuss Brainstorming in Medical Device Development and wearing “Six Hats”
Cameron Loper and Brian Scrivens of MPR Associates discuss brainstorming and how it can bring a medical device to market.
Featured Articles
Polymedix’s antibiotics are designed to imitate the mechanism of natural human immunity
PolyMedix has a pipeline of innovative infectious disease and cardiovascular product candidates.
Rodman & Renshaw Launches DirectMarkets: First-Ever 24/7 Automated Electronic Transaction Platform
Rodman & Renshaw Capital Group, Inc. will unveil an automated state-of-the-art electronic transaction platform to directly link issuers and investors.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
TDI-132 shows promising results in the treatment of ALS
ALS may be the most deadly disease many people have never heard of. Also referred to as Lou Gehrig’s disease, it affects at least 30,000 people in the United States and 450,000 people worldwide.
Producer of Advamed 2012, Ray Briscuso Leads One of The Largest MedTech Conferences in a New Direction
AdvaMed 2012, the big medtech conference for industry executives, has launched its website and is calling for proposals for program panels.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
“Inside the FDA” session at BIO CEO Addressed PDUFA and TREAT Acts
This is one of the largest sources of frustration currently among health care companies and investors.
This Week in Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
BIO CEO & Investor Conference Has Grown in Size and Offered Insight on Industry Mood
According to BIO’s statistics, “a majority of investors (56%) still think now is a good time to invest.